15936-81-9 Usage
Uses
Used in Pharmaceutical Research:
5-Bromo-7-methyl-1H-indole is used as a key intermediate in the synthesis of various bioactive molecules and pharmaceutical compounds. Its unique chemical structure allows for the development of new drugs with potential therapeutic applications.
Used in Chemical Research:
5-Bromo-7-methyl-1H-indole is utilized as a building block in the synthesis of complex organic molecules, contributing to the advancement of chemical research and the discovery of novel chemical entities.
Used in Drug Development:
5-Bromo-7-methyl-1H-indole is employed as a starting material in the development of new drugs, particularly those with anti-inflammatory and anti-tumor properties. Its diverse biological activities make it a promising candidate for the treatment of various diseases and conditions.
Used in Agrochemical Development:
5-Bromo-7-methyl-1H-indole is used as a precursor in the synthesis of agrochemicals, such as pesticides and herbicides. Its unique chemical properties can potentially lead to the development of more effective and environmentally friendly agrochemicals.
Check Digit Verification of cas no
The CAS Registry Mumber 15936-81-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,5,9,3 and 6 respectively; the second part has 2 digits, 8 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 15936-81:
(7*1)+(6*5)+(5*9)+(4*3)+(3*6)+(2*8)+(1*1)=129
129 % 10 = 9
So 15936-81-9 is a valid CAS Registry Number.
15936-81-9Relevant academic research and scientific papers
Preparation method of 5-bromo-7-methylindole
-
Paragraph 0061; 0076-0083; 0098-0105; 0120-0127; 0142-0148, (2021/07/01)
The invention discloses a preparation method of 5-bromo-7-methylindole. The structure of an intermediate corresponds to a formula V. The preparation method comprises the following steps: using 4-bromo-2-methylaniline as an initial raw material, and carryi
Calcitonin gene related peptide receptor antagonists
-
, (2008/06/13)
The present invention relates to compounds of Formula (I) as antagonists of calcitonin gene-related peptide receptors (“CGRP-receptor”), pharmaceutical compositions comprising them, methods for identifying them, methods of treatment using them and their use in therapy for treatment of neurogenic vasodilation, neurogenic inflammation, migraine and other headaches, thermal injury, circulatory shock, flushing associated with menopause, airway inflammatory diseases, such as asthma and chronic obstructive pulmonary disease (COPD), and other conditions the treatment of which can be effected by the antagonism of CGRP-receptors.
